Hargitai G, Sólyom J, Battelino T, Lebl J, Pribilincová Z, Hauspie R, Kovács J, Waldhauser F, Frisch H
2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
Horm Res. 2001;55(4):161-71. doi: 10.1159/000049990.
Longitudinal growth and bone age (BA) development are the most important clinical parameters for monitoring adequate glucocorticoid replacement in children with congenital adrenal hyperplasia (CAH).
To analyze the growth pattern of patients treated for CAH of the salt wasting (SW) and simple virilizing (SV) clinical forms; to evaluate final height as compared to reference data and individual target height; to evaluate the course of BA development.
A large database of 598 patients with CAH was created in 5 Central European countries and growth data of 341 treated patients with 21-hydroxylase deficiency were analyzed retrospectively. The patients were of Caucasian origin. Centiles were constructed in a cross-sectional manner and an additional longitudinal analysis was performed in order to evaluate the pubertal growth spurt by applying particular statistical methods (Preece-Baines model).
The growth of SW CAH patients was impaired in infancy and early childhood (0-3 years of age), but followed normal patterns in childhood until puberty. In contrast, children with SV CAH had normal patterns of growth in infancy and early childhood and were considerably taller than healthy references during childhood. In the longitudinal study, peak height velocity in both boys and girls was normal, but it occurred at an earlier age than in the standard population. The final height of patients with CAH was reduced in comparison to both the reference and the individual target height. No correlations were found between final height and age at the start of the therapy in SV patients or between final height and year of birth. BA was advanced in both types of CAH, but more accelerated in SV patients.
Characteristic growth patterns for treated SV and SW CAH children were identified, with a normal pubertal growth spurt and reduced final height being observed.
纵向生长和骨龄(BA)发育是监测先天性肾上腺皮质增生症(CAH)患儿糖皮质激素替代治疗是否充分的最重要临床参数。
分析盐耗竭型(SW)和单纯男性化型(SV)先天性肾上腺皮质增生症患者的生长模式;将最终身高与参考数据及个体靶身高进行比较评估;评估骨龄发育过程。
在5个中欧国家建立了一个包含598例先天性肾上腺皮质增生症患者的大型数据库,并对341例接受治疗的21 - 羟化酶缺乏症患者的生长数据进行回顾性分析。患者为白种人。以横断面方式构建百分位数,并采用特定统计方法(普里斯 - 贝恩斯模型)进行额外的纵向分析,以评估青春期生长突增。
SW型先天性肾上腺皮质增生症患者在婴儿期和幼儿期(0 - 3岁)生长受损,但在儿童期直至青春期遵循正常模式。相比之下,SV型先天性肾上腺皮质增生症患儿在婴儿期和幼儿期生长模式正常,且在儿童期比健康对照者高得多。在纵向研究中,男孩和女孩的身高生长速度峰值均正常,但发生年龄比标准人群早。与参考身高和个体靶身高相比,先天性肾上腺皮质增生症患者的最终身高降低。SV型患者的最终身高与治疗开始时的年龄之间或最终身高与出生年份之间均未发现相关性。两种类型的先天性肾上腺皮质增生症患者骨龄均提前,但SV型患者更为加速。
确定了接受治疗的SV型和SW型先天性肾上腺皮质增生症患儿的特征性生长模式,观察到青春期生长突增正常但最终身高降低。